🔗 Share this article

Acclaimed R&B singer D’Angelo passed away on the fourteenth of October at 51 years old after a personal fight with pancreatic malignancy.

“The shining star of our family has dimmed his light for us in the present world,” his relatives stated. “After a lengthy and brave battle with cancer, we are deeply saddened to announce that Michael D’Angelo Archer, known to his followers around the globe as D’Angelo, has been taken from us.”

D’Angelo left an indelible mark on music with his innovative neo-soul sound and partnerships with high-profile artists.

He launched his debut album, “Brown Sugar,” in the mid-nineties to immediate acclaim. The album achieved the fourth spot on the R&B charts, earned platinum status soon after, and received multiple Grammy nominations.

However, it was his second album, “Voodoo,” in 2000 that propelled his music career into the limelight. The album debuted at the top spot on both the R&B charts and the Billboard 200. He won two Grammys: Top R&B Record and Best Male R&B Vocal Performance for “Untitled (How Does It Feel).”

The visual for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a sex symbol, albeit a hesitant one, in the cultural zeitgeist. The personal depiction featured the artist, famously bare to his midsection, performing directly into the camera.

D’Angelo stepped back from the public eye after releasing Voodoo and publicly struggled with drugs and alcohol. In 2005, he was involved in a severe vehicle accident that left him in critical condition.

Over ten years later, his third and final album, “Black Messiah” (2014), confirmed his enduring appeal with another top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own mysterious way, D’Angelo had limited public appearances in the subsequent period.

The musician was announced as a top act for the 2025 music event, but his performance was canceled, due to an “unforeseen medical delay.”

Even though information is limited about D’Angelo’s well-being in the weeks before his death, he had apparently been hospitalized for months and in palliative care for a fortnight.

D’Angelo’s demise is a clear example of the devastating effects of pancreatic cancer, one of the deadliest and least preventable types of the disease, on a gifted artist whose existence was cut short.

“We are saddened that he can only provide dear memories with his family, but we are eternally grateful for the heritage of deeply emotional music he leaves behind,” his kin expressed.

Pancreatic Malignancy: Lethal and Difficult to Avoid

Pancreatic cancer affects the pancreas, a small organ that generates insulin and is vital in digestion, among other functions. The position and dimensions of the pancreas in the body make it more challenging to identify malignancy.

Although pancreatic cancer makes up only approximately three percent of malignancy cases each year in the United States, it is responsible for 7% of malignancy fatalities.

Almost 70,000 people will be diagnosed with pancreatic cancer and about 52,000 will succumb to the disease in 2025.

“Pancreatic cancer is one of the most lethal diseases, with an fast-growing mass and poor prognosis. We have few and poor treatment options, and a narrow opportunity to make a meaningful impact on the lives of patients,” said a cancer specialist.

Because pancreatic cancer rarely causes early symptoms, it’s frequently identified only after the disease is advanced. Even when a individual has symptoms they are usually vague and may be mistaken for a several common illnesses.

“Currently, there is no good way to identify this malignancy in the early stages, except for listening to your body and consulting your physician if there are new or unusual signs,” said a health expert.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• reduced body mass
• jaundice
• reduced hunger
• dark urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• feeling sick

At age 51, D’Angelo’s death is an exception, as this malignancy is most common in adults in the 65 to 75 age bracket. However, numerous malignancies, such as this type, have become increasingly prevalent in younger adults.

“This disease identified before the age of 50 is deemed uncommon, yet concerningly, clinicians are noticing a growing number of younger patients affected by this disease,” commented a expert.

Family History Impacts Cancer Risk

In the absence of effective detection methods for this malignancy, professionals emphasized the importance of understanding your family’s health background. Certain contributing elements, such as tobacco use and excess weight also play a role in the onset of this disease.

Black individuals have the highest incidence of this malignancy in the United States and are more prone to be found to have inoperable cancer.

“The first step toward reducing one’s risk of pancreatic cancer is understanding personal risk factors. People should review their genetic background, hereditary factors, and health issues, such as blood sugar disease, chronic pancreatitis, or overweight that may raise their vulnerability,” said a specialist.

Hereditary risk factors are associated with as much as 10% of all this malignancy cases. If someone in your household has had pancreatic cancer, you may want to think about genetic testing.

“For individuals with a relative’s background of this condition or those having elevated risk DNA changes, checking may involve advanced imaging such as MRI scans or endoscopic ultrasound (EUS) to find initial alterations in the organ,” he clarified.

For those wishing to lower their chance, lifestyle changes may make a difference. The most effective step you can take to lower your risk of this disease is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy alcohol consumption is associated with pancreatitis, a contributing element for pancreatic cancer, so reducing or avoiding drinks may help lower your chance.

Managing your body mass or shedding pounds may also aid reduce your risk. Individuals with obesity are 20% more likely to develop pancreatic cancer. This malignancy also is more frequent in people with diabetes, and weight loss can also reduce the risk of adult-onset diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and more recent mixed drug treatments. There are developing targeted therapies that are already showing results,” said a specialist.

For numerous individuals, however, awareness about this rare but {dev